Macoil

Omega-3-acid ethyl esters, the active ingredient in Macoil, is a omega-3 fatty acid presented as an oral formulation for oral use. It is used to help manage elevated triglyceride concentrations in adult patients as part of a lipid-lowering strategy.

GNH USA supplies Macoil as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to European Union quality standards and provides regulatory documentation for cross-border procurement.

Macoil, an omega-3 fatty acid ethyl ester, is used to address disorders of lipid metabolism, particularly elevated triglyceride levels.

- Hypertriglyceridemia: reduces plasma triglyceride concentrations as an adjunct to diet. - Familial hyperchylomicronemia: helps lower extremely high triglyceride levels in genetically predisposed individuals. - Cardiovascular risk reduction (adjunct): may be used alongside statin therapy to support overall lipid management.

Oral omega-3 ethyl esters are generally well tolerated, but several adverse reactions have been reported.

Common Side Effects: - Fishy aftertaste or belching. - Nausea or mild stomach upset. - Diarrhea or loose stools. - Abdominal discomfort or bloating.

Serious or Rare Side Effects: - Acute pancreatitis. - Severe allergic reactions, including rash or angioedema. - Bleeding complications, especially when combined with anticoagulants. - Elevated liver enzymes (ALT/AST).

When prescribing or dispensing Macoil, consider the following precautions to ensure safe use.

- Assess triglyceride levels: confirm indication before initiating therapy. - Monitor for bleeding: caution in patients on anticoagulants or with bleeding disorders. - Evaluate liver function: periodic testing recommended for patients with hepatic disease. - Pregnancy and lactation: use only if potential benefit outweighs risk, as safety data are limited. - Concomitant fish oil supplements: avoid duplicate dosing to reduce gastrointestinal irritation. - Store at ambient temperature: keep below 25 °C in the original container, protect from moisture and direct sunlight.

Omega-3 ethyl esters can affect the pharmacodynamics or pharmacokinetics of several medicines.

Major Interactions (Avoid): - Anticoagulants (warfarin, direct oral anticoagulants): increased bleeding risk. - High-dose vitamin E: additive anticoagulant effect. - Other omega-3 or fish-oil products: risk of excessive dosing and gastrointestinal upset.

Moderate Interactions (Monitor Closely): - Statins: potential for mild increase in muscle-related symptoms. - Antihypertensive agents: possible additive blood-pressure lowering effect. - Immunosuppressants (e.g., cyclosporine): may alter drug levels; monitor concentrations.